Active, Not Recruiting
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
NCT03360890
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +11 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States